Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could inducing labor at 39 weeks cut C-Sections in obese moms?

NCT ID NCT04603859

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether inducing labor at 39 weeks of pregnancy is better than waiting for labor to start naturally in women with a BMI of 30 or higher. The goal is to see if early induction lowers the chance of needing a C-section. About 1,900 women in Denmark will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
elective induction of labor (procedure)
What this could lead to
If it works, this could show that inducing labor at 39 weeks lowers the need for C-sections in obese women, leading to safer births.
What could go wrong
This is a large trial, but results may not apply to all hospitals or women. Inducing labor can also have risks like longer labor or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,900 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2020

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: • Pregnant women with pre- or early pregnancy BMI ≥ 30 kg/m2 Exclusion Criteria: * Legal or ethical considerations: maternal age \<18 years, language difficulties requiring an interpreter or translator * Multiple pregnancy * Previous caesarean section * Uncertain gestational age, defined as gestational age determined by other measurements than the Crown-Rump length (CRL) Measurement * Planned elective caesarean section at time of randomisation * Fetal contraindications to IOL at time of randomisation: e.g. non-cephalic presentation, or other fetal conditions contraindicating vaginal delivery * Fetal contraindications to expectant management at time of randomisation * Maternal contraindications to IOL at time of randomisation: e.g. placenta previa/accreta, vasa previa * Maternal contraindications to expectant management at time of randomisation: e.g. maternal medical conditions, ultrasonically diagnosed oligohydramnios (DVP\< 2 cm), signs of labour including pre-labour rupture of membranes (PROM)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aarhus University Hospital

    RECRUITING

    Aarhus, Denmark

  • Gødstrup Regional Hospital

    RECRUITING

    Herning, Denmark

  • Herlev Hospital

    RECRUITING

    Herlev, Denmark

  • Hvidovre Hospital

    RECRUITING

    Hvidovre, Denmark

  • Kolding Hospital

    RECRUITING

    Kolding, Denmark

  • North Zealand's Hospital

    RECRUITING

    Hillerød, Denmark

  • Nykøbing Falster Hospital

    RECRUITING

    Nykøbing Falster, Denmark

  • Odense University Hospital

    RECRUITING

    Odense, Denmark

  • Randers Regional Hospital

    RECRUITING

    Randers, Denmark

  • Rigshospitalet Juliane Marie Centre

    RECRUITING

    Copenhagen, Denmark

  • Viborg Hospital

    RECRUITING

    Viborg, Denmark

  • Zealand University Hospital

    RECRUITING

    Roskilde, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.